다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc (ATRA) 뉴스

ATRA

Atara Biotherapeutics (ATRA)

Atara Biotherapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ATRA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/08	06:01	Business Wire	Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/02/07	08:34	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/30	06:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/28	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/21	21:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/21	21:30	Business Wire	Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/18	06:06	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/17	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2025/01/16	22:30	Business Wire	Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLOTM (tabelecleucel)	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/12/24	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/28	06:01	Business Wire	Atara Biotherapeutics to Participate at the 7th Annual Evercore ISI HealthCONx Conference	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/21	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/21	08:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/21	08:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/19	07:58	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/19	07:56	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/19	07:55	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/19	07:54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/14	06:01	Business Wire	Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/13	06:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/13	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/13	06:01	Business Wire	Atara Biotherapeutics Announces Third Quarter 2024 Financial Results and Operational Progress	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/11/06	06:01	Business Wire	Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/10/16	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/10/05	05:01	Business Wire	Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/09/12	06:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/09/07	05:01	Business Wire	Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/09/06	07:42	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/09/06	05:07	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ATRA	Atara Biotherapeutics Inc
2024/09/05	05:42	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ATRA	Atara Biotherapeutics Inc

검색 관련기사 보기:NASDAQ:ATRA

1 2 3 4 5 6 7 8 9 10 다음 >>

Energy Select Sector SPDR

US Dollar vs Yen

BNP Paribas (QX)

Financial Select Sector

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관